
SMI-16a
CAS No. 587852-28-6
SMI-16a( Pim1/2 Inhibitor IV | PIM1/2 Kinase Inhibitor VI )
Catalog No. M17550 CAS No. 587852-28-6
PIM1/2 Kinase Inhibitor VI, a cell-permeable thiazolidinedione compound, acts as an effective, ATP-competitive inhibitor against Pim-1/2 kinases (IC50: 150/20 nM).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 36 | In Stock |
![]() ![]() |
5MG | 58 | In Stock |
![]() ![]() |
10MG | 80 | In Stock |
![]() ![]() |
25MG | 147 | In Stock |
![]() ![]() |
50MG | 222 | In Stock |
![]() ![]() |
100MG | 335 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameSMI-16a
-
NoteResearch use only, not for human use.
-
Brief DescriptionPIM1/2 Kinase Inhibitor VI, a cell-permeable thiazolidinedione compound, acts as an effective, ATP-competitive inhibitor against Pim-1/2 kinases (IC50: 150/20 nM).
-
DescriptionSMI-16a, also known as Pim1/2 Inhibitor IV, is a potent, cell-permeable, ATP-competitive inhibitor of Pim-1/2 kinases (IC50 = 150 nM and 20 nM against Pim-1 and Pim-2, respectively).
-
In Vitro——
-
In Vivo——
-
SynonymsPim1/2 Inhibitor IV | PIM1/2 Kinase Inhibitor VI
-
PathwayGPCR/G Protein
-
TargetGPCR19
-
RecptorPim1| Pim2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number587852-28-6
-
Formula Weight263.31
-
Molecular FormulaC13H13NO3S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 150 mg/mL; 569.67 mM
-
SMILESCCCOC1=CC=C(C=C1)/C=C\2/C(=O)NC(=O)S2
-
Chemical Name(Z)-5-(4-Propoxybenzylidene)thiazolidine-2,4-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xia Z., et al. Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases. J Med Chem. 2009 Jan 8;52(1):74-86.
molnova catalog



related products
-
TGR5
TGR5 Receptor Agonist, a potent TGR5(GPCR19) agonist, showed improved potency in the U2-OS cell assay (pEC50 = 6.8) and in melanophore cells (pEC50 = 7.5).
-
TC-G 1005
TC-G 1005 is a potent and selective GPBA agonist (EC50 :0.72 nM; hTGR5). Selective for TGR5 over FXR (farnesoid X receptor). Increases plasma GLP-1 levels and reduces blood glucose in mice.
-
SBI-115
SBI-115 is an?antagonist of?TGR5.?SBI-115 decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.